Systolic and diastolic dysfunction in long-term adult survivors of childhood cancer
- PMID: 21696947
- DOI: 10.1016/j.ejca.2011.05.023
Systolic and diastolic dysfunction in long-term adult survivors of childhood cancer
Abstract
Aim: To assess systolic and diastolic function in adult childhood-cancer survivors (CCS) after treatment entailing potential cardiovascular toxicity.
Methods: The study cohort consisted of 277 adult CCS (median age 28 [range 18-48]years), who had been treated with anthracyclines, platinum, and/or radiotherapy between 1976 and 1999, along with 130 healthy sibling controls. The assessments included echocardiography, baroreflex sensitivity measurement, and plasma N-terminal pro-brain natriuretic peptide (NT-proBNP). Echocardiography measurements were shortening fraction (SF) (abnormal<29%) for systolic function and tissue velocity imaging of early diastole (TVI Et) (abnormal<8.00)cm/sec for diastolic function; systolic function was also assessed by the wall motion score index (WMSI).
Results: At 18 (5-31)years post-treatment, the prevalence of both impaired SF and abnormal WMSI was increased in CCS compared to controls (p=0.003 and p<0.001, respectively). CCS also had an increased prevalence of diastolic dysfunction compared to the controls (12% versus 1%, p<0.001). Abnormal SF and/or abnormal diastolic function were found in 43% of CCS. NT-proBNP was higher in CCS and was associated to increased WMSI. Baroreflex sensitivity was lower in CCS and was associated with diastolic dysfunction. Systolic as well as diastolic dysfunction was associated with cumulative dose of anthracyclines and mediastinal irradiation.
Conclusion: After treatment with potential cardiovascular toxic therapies, the risk of systolic and diastolic dysfunction in CCS is considerable. Since these abnormalities, in particular diastolic dysfunction, are age related, the observed effects might be considered a sign of precocious cardiac ageing.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines.Pediatr Blood Cancer. 2009 May;52(5):631-6. doi: 10.1002/pbc.21913. Pediatr Blood Cancer. 2009. PMID: 19127569
-
Can pro-brain natriuretic peptide be used as a noninvasive predictor of elevated left ventricular diastolic pressures in patients with normal systolic function?Am Heart J. 2005 Dec;150(6):1213-9. doi: 10.1016/j.ahj.2005.01.014. Am Heart J. 2005. PMID: 16338261
-
Serum NT-proBNP concentrations in the early phase do not predict the severity of systolic or diastolic left ventricular dysfunction among patients with ST-elevation acute myocardial infarction.Angiology. 2006 Dec-2007 Jan;57(6):686-93. doi: 10.1177/0003319706295228. Angiology. 2006. PMID: 17235108
-
Biomarkers to diagnose ventricular dysfunction in childhood cancer survivors: a systematic review.Heart. 2019 Feb;105(3):210-216. doi: 10.1136/heartjnl-2018-313634. Epub 2018 Aug 29. Heart. 2019. PMID: 30158136
-
Is health status impaired in childhood cancer survivors? A systematic review and meta-analysis.Crit Rev Oncol Hematol. 2019 Oct;142:94-118. doi: 10.1016/j.critrevonc.2019.07.008. Epub 2019 Jul 29. Crit Rev Oncol Hematol. 2019. PMID: 31394434
Cited by
-
Educational paper: decreasing the burden of cardiovascular disease in childhood cancer survivors: an update for the pediatrician.Eur J Pediatr. 2013 Sep;172(9):1149-60. doi: 10.1007/s00431-013-1931-9. Epub 2013 Jan 30. Eur J Pediatr. 2013. PMID: 23361962 Review.
-
Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens.Heart Fail Rev. 2019 Nov;24(6):915-925. doi: 10.1007/s10741-019-09820-2. Heart Fail Rev. 2019. PMID: 31256318 Review.
-
Cancer Therapy-Related Cardiac Dysfunction in Patients Treated with a Combination of an Immune Checkpoint Inhibitor and Doxorubicin.Cancers (Basel). 2022 May 7;14(9):2320. doi: 10.3390/cancers14092320. Cancers (Basel). 2022. PMID: 35565449 Free PMC article.
-
Prevalence and predictors of prescription psychoactive medication use in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.J Cancer Surviv. 2013 Mar;7(1):104-14. doi: 10.1007/s11764-012-0250-x. Epub 2012 Dec 8. J Cancer Surviv. 2013. PMID: 23224753 Free PMC article.
-
Assessment of late cardiotoxic effects in patients treated for cancer in childhood.Cancer Med. 2022 Apr;11(8):1763-1768. doi: 10.1002/cam4.4564. Epub 2022 Feb 15. Cancer Med. 2022. PMID: 35166044 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials